My Companies
Notification
Account
Log Out
Login
The FCCB Committee approved conversion of USD1.5 million of FCCBs into 4,811,730 equity shares at ₹30.19 each, increasing shares outstanding 1.9% to 254.47 million and paid-up capital to ₹25.45 crore. Context: this is a partial conversion under the broader FCCB programme.
Sudarshan Pharma Approves 9.5% MedTherapy Biotechnology Stake Acquisition
Sudarshan Pharma Promoters Pledge 66.5 Lakh Shares Each To Satin Finserv
Sudarshan Pharma Industries Promoters Pledge 1.32 Crore Shares To Satin Finserv
Sudarshan Pharma Creates 3.25% Promoter Pledge To Secure Company Loan
Sudarshan Pharma Allots 90 Lakh Shares on Promoter Warrant Conversion